News & Updates
Keep Me Updated
General Info
Mark your Calendar - Join us in February 2010!
| Prof. Uri Elkayam | OTHER IMPORTANT EVENTS | |
| Congress Chairman | International Academy of Cardiology | |
| 15th World Congress on Heart Disease | ||
| Dr. Avraham Shotan | Annual Scientific Sessions 2010 | |
| Congress Co-Chairman | July 24-27, 2010, Vancouver, BC, Canada | |
| www.cardiologyonline.com |
Registration
Registration for the congress is closed. Registration will be available on-site only. For more information, Click Here
Accommodation for the congress is closed. For more information, Click Here
Sponsorship
A commercial and professional exhibition will take place during the meeting parallel to the congress hours.
To view the Prospectus and contact the Sales and Exhibition Liason Click Here
Program
Secretariat
Paragon Conventions
18 Avenue Louis-Casaï
1209 Geneva, Switzerland
Tel:
E-mail: secretariat@cpp2010.com
| Presentations |
|
Friday, February 26, 2010 07:30 - 18:30 Registration 09:05 Opening Lecture: 09:15 Peripartum Cardiomyopathy - State of the Art 09:55-11:20 PL1 - Cardiac Evaluation of the Pregnant Woman 09:55 Hemodynamics and Cardiac Function during Pregnancy and the Puerperium 10:10 Maternal Hemodynamics in Normal Pregnancy and Impact on Heart Disease 10:25 Pre Eclampsia and Future Heart Disease 10:40 Echocardiographic Changes During Pregnancy: What is Normal and What is Not? 10:55 Cardiac Magnetic Resonance in Pregnant Women: Supine or Left Lateral Position? 11:05 Cardiac Markers in Pregnancy 11:20-11:45 Coffee Break 11:45 Preconception Evaluation of the Woman with Congenital Heart Disease 12:00 Preconception Counseling of the Patient with Congenital Heart Disease 12:15 Preconception Evaluation of Women with Valvular Heart Disease 12:30 Initial Experience of a Designated Preconception Counselling Service for Women with Heart Disease at University College London Hospitals (UCLH), UK 12:40 Preconceptional Counselling Clinic for Young Women with Congenital Heart Disease 12:50 Reproductive Health and Contraception in Women with Congenital Heart Disease 13:00 Preconception Risk Assessment in Patients with Heart Disease 13:15 - 14:30 Light Lunch 14:30 - 15:45 Parallel Sessions S1-2 14:30 - 15:45 S1 - Fetal Heart Disease 14:30 Cardiac Function in Normal and Growth Restricted Fetuses 14:45 3D/4D Ultrasound in Fetal Echocardiography: A New Look at the Fetal Heart 15:15 Technical Advances in Fetal Echocardiography 15:30 Fetal Venous System: Sonographic Evaluation and Assessment of Fetal Growth and 14:30-15:45 S2- Acute Myocardial Infarction and Drugs in Pregnancy and Lactation 14:30 Acute Myocardial Infarction in Pregnancy: Incidence and Pathopysiology 14:45 Acute Myocardial Infarction and Pregnancy: Clinical Profile 15:00 Anesthetic Management of a Parturient with an Antenatal Myocardial Infarction and 15:10 Pre-Pregnancy Consultations & Management of Pregnancy in Women Treated with 15:20 Peri-post Partum Coronary Complications 15:30 Resuscitation of Patients with Acute Myocardial Infarction during Pregnancy 15:45 - 16:10 Coffee Break 16:10 Cardiac Causes of Maternal Death in the UK Catherine Nels on-Piercy Guy's & St Thomas' Hospital, London, UK 16:25 European Survey On CV Disease In Pregnancy 16:45 - 18:10 PL4 - Congenital Heart Disease 16:45 Pregnancy in Women with Non-Cyanotic Congenital Heart Disease 17:00 The Right Ventricle in Congenital Heart Disease and Pregnancy 17:15 Pregnancy in Women with Complex Congenital Heart Disease 17:30 Pregnancy Related Complications in Congenital Heart Disease: European Experience 17:45 The Incidence of Congenital Heart Disease in the Offspring of Women with Heart Defects 18:00 Prospective Evaluation from Single Center of Pregnancy in Women with Congenital Heart Disease 18:10-19:30 Guided Poster Session saturday, February 27, 2010 08:30-10:00 PL5-Peripartum Cardiomyopathy 08:30 Peripartum Cardiomyopathy Is an Auoimmune Disease. 08:45 The Prolactin Hypothesis and Results of Clinical Trials 09:00 Myocardial Recovery in Peripartum Cardiomyopathy: Lessons from IMAC2 and Study Design of IMAC3 09:15 Racial Differences in Phenotypic Expression of Peripartum Cardiomyopathy 09:30 Recovery of Heart Function in Women With Severe Heart Failure from Peripartum Cardiomyopathy: An 8-Year Longitudinal Study from Haiti 09:45 Nationwide Survey of Peripertum Cardiomyopathy in Japan 09:55 Risk Factors for Peripartum Cardiomyopathy, Prognosis for Recovery and Recurrence in Subsequent Pregnancies 10:15 Panel Discussion 10:30-11:00 Coffee Break 11:00 Hypertrophic Cardiomyopathy and Pregnancy. What is the Risk? 11:15 Hypertrophic Cardiomyopathy and Pregnancy: Hemodynamic and Physiological Observation and Clinical Implications 11:30 The Risk of Pregnancy in the Patient with Dilated, Non Ischemic Cardiomyopathy 11:45 Chagas Disease and Pregnancy. Alleatory Study in Barcelona 11:55 Left Ventricular Non-compaction and Pregnancy 12:10 Pregnancy after Heart Transplantation: Is It Safe? 12:25 Case Report - Nonischemic Dilated CMP: Multidisciplinary Approach 12:40-14:00 Light Lunch 14:00-16:00 PL7 - Valvular Heart Disease 14:00 Candice Silversides Rheumatic Heart Disease and Pregnancy 14:15 Mitral Stenosis 14:30 Aortic Stenosis 14:45 Pulmonary Stenosis 15:00 Prosthetic Heart Valves and Pregnancy 15:15 Selection of Prosthetic Heart Valve in Pregnancy 15:25 Debate - Low Molecular Heparin is the Anticoagulation of Choice in Pregnant Women with Mechanical Heart Valve 16:00-16:25 Coffee Break 16:25-17:25 Parallel Session S3-4 16:25-17:10 S3 - Thromboembolic Complication and Pregnancy 16:25 Pulmonary Embolism in Pregnancy 16:40 Hypercoagulability and Pregnancy 16:55 Amniotic Fluid Embolism 17:10 Deep Vein Thrombosis and Pregnancy
16:25 Management of Cardiac Pregnant Patients with Prosthetic Valves : Five Years Experience 16:35 Successful Pregnancy Following Relief of Pulmonary Regurgitation Using a Percutaneous Pulmonary Valved Stent 16:45 Risk Factors Associated with Cardiac Surgery during Pregnancy 16:55 Does Pregnancy Contribute to Systemic RV Dysfunction in Adults with the Atrial Switch Operation? 17:05 Anesthetic Implications for Labor and Delivery in a Single-Ventricle Parturient 17:15 Pregnancy Outcome in Women with Single Ventricle Physiology and Fontan Circulation 17:25-17:35 BREAK 17:35-18:35 Parallel Sessions S5-6 17:35-18:30 S5 - Congenital and Fetal Heart Disease 17:35 Cardiovascular Manifestations of the Twin-Twin Transfusion Syndrome 17:55 Fetal Surgical Interventions 18:10 Intrapartum Fetal Heart Rate Monitoring In Cases of Congenital Heart Disease. 18:20 Fetal and Perinatal Factors Influence Neurocognitive Outcome in Congenital Heart Disease 17:35-18:20 S6 - Vascular Disease and Pregnancy 17:35 Aortic Aneurysm, Dissection and Pregnancy 17:50 Approach to the Pregnant Patient with Marfan Syndrome 18:05 Pregnancy in Women with Takayasu’s Arteritis Sunday, February 28, 2010
08:30 Cardiac Arrhythmias and Pregnancy. Incidence, Prognosis, Diagnosis and Management 08:45 Fetal Safety of Cardiovascular Drugs 09:15 Maternal Outcome in Women with an Implantable Cardioverter Defibrillator (ICD) - A Single Centre Experience, at University College London Hospitals (UCLH) 09:25 Cardiopulmonary Arrest in Pregnancy. Case Report. 09:35 Fetal Arrhythmias: Diagnosis and Management 09:50-10:20 PL9 - Pulmonary Hypertension in Pregnancy 09:50 Pulmonary Hypertension and Pregnancy – Why Do Women Die? 10:05 Pregnancy and Pulmonary Arterial Hypertension: Successful Management of 37 10:20-10:45 Coffee Break 10:45 Choice of Uterotonic Drugs in the Cardiac Patient: What We Do and Don’t Know 11:15 Cardiac Surgery in the Pregnant Patient: The View of the Surgeon. 11:30 Key Questions in Planning for Delivery of the Cardiac Patient 11:45 How to Deliver an Effective Anesthesia for the Delivery of a Cardiac Patient? 12:00-13:10 PL11 - Hypertension and Pregnancy 12:00 Hypertension and Pregnancy: Classification, Diagnosis and Treatment 12:15 Pre Eclampsia: Can It Be Prevented? 12:30 Cardiovascular Catas trophes in Pregnancy 12:45 Preterms Delivered Because of Early-onset Pre-eclampsia Show Increased Risk of Metabolic Disturb and Death, When Compared to Untreated Normotensive 12:55 Cardiac Evaluation During Pregnancy |














